{"id":"https://openalex.org/W2153454736","doi":null,"title":"Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis.","display_name":"Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis.","publication_year":2010,"publication_date":"2010-10-01","ids":{"openalex":"https://openalex.org/W2153454736","mag":"2153454736","pmid":"https://pubmed.ncbi.nlm.nih.gov/21036702"},"language":"en","primary_location":{"id":"pmid:21036702","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21036702","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Yan Cao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16568816","display_name":"Kanazawa Medical University","ror":"https://ror.org/0535cbe18","country_code":"JP","type":"education","lineage":["https://openalex.org/I16568816"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yan Cao","raw_affiliation_strings":["Department of Hematology and Immunology, Kanazawa Medical University, Kahoku-gun, Ishikawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Immunology, Kanazawa Medical University, Kahoku-gun, Ishikawa, Japan","institution_ids":["https://openalex.org/I16568816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028431857","display_name":"Zhe-Xiong Jin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhe-Xiong Jin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110198097","display_name":"Xiaopeng Tong","orcid":"https://orcid.org/0009-0002-0504-1066","observed_orcids":["https://orcid.org/0009-0002-0504-1066"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiao-Peng Tong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Sun Yue","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sun Yue","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069916638","display_name":"Tomoyuki Sakai","orcid":"https://orcid.org/0000-0002-5533-3465","observed_orcids":["https://orcid.org/0000-0002-5533-3465"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomoyuki Sakai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111992506","display_name":"Takafumi Kawanami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takafumi Kawanami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073388784","display_name":"Toshioki Sawaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshioki Sawaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019926116","display_name":"Miyuki Miki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miyuki Miki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090521080","display_name":"Haruka Kawanami Iwao","orcid":"https://orcid.org/0000-0002-4986-5473","observed_orcids":["https://orcid.org/0000-0002-4986-5473"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haruka Iwao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003204127","display_name":"Akio Nakajima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akio Nakajima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061841627","display_name":"Yasufumi Masaki","orcid":"https://orcid.org/0000-0002-5658-3765","observed_orcids":["https://orcid.org/0000-0002-5658-3765"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yasufumi Masaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084496298","display_name":"Yoshihiko Fukushima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshihiko Fukushima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109831763","display_name":"Yoshimasa Fujita","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yoshimasa Fujita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105696825","display_name":"Hideo Nakajima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hideo Nakajima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091657418","display_name":"Toshiro Okazaki","orcid":"https://orcid.org/0000-0002-1667-841X","observed_orcids":["https://orcid.org/0000-0002-1667-841X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshiro Okazaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014411218","display_name":"Hisanori Umehara","orcid":"https://orcid.org/0000-0001-9833-4647","observed_orcids":["https://orcid.org/0000-0001-9833-4647"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hisanori Umehara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1062,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.40891331,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"30","issue":"10","first_page":"3911","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9394999742507935,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9394999742507935,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.05920000001788139,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sn-38","display_name":"SN-38","score":0.9729999899864197},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.8840000033378601},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.8389999866485596},{"id":"https://openalex.org/keywords/fas-mediated-apoptosis","display_name":"Fas-mediated apoptosis","score":0.8050000071525574},{"id":"https://openalex.org/keywords/synergistic-drug-combination","display_name":"synergistic drug combination","score":0.7710000276565552},{"id":"https://openalex.org/keywords/caspase-3-activation","display_name":"caspase-3 activation","score":0.8690000176429749},{"id":"https://openalex.org/keywords/camptothecin-analogs","display_name":"camptothecin analogues","score":0.8100000023841858}],"concepts":[{"id":"https://openalex.org/C2779682216","wikidata":"https://www.wikidata.org/wiki/Q419964","display_name":"Camptothecin","level":2,"score":0.9165585041046143},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.9002770781517029},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.8420301675796509},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.6451170444488525},{"id":"https://openalex.org/C85265743","wikidata":"https://www.wikidata.org/wiki/Q885458","display_name":"Blot","level":3,"score":0.5930381417274475},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5734577178955078},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.44912150502204895},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40201035141944885},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3860261142253876},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3720710873603821},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2689969539642334},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2004048228263855},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.1643843948841095},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13237303495407104},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1096494197845459},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.10852357745170593}],"mesh":[{"descriptor_ui":"D000071877","descriptor_name":"Checkpoint Kinase 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004268","descriptor_name":"DNA-Binding Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019014","descriptor_name":"fas Receptor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019014","descriptor_name":"fas Receptor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D025521","descriptor_name":"Tumor Suppressor Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053148","descriptor_name":"Caspase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D064007","descriptor_name":"Ataxia Telangiectasia Mutated Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:21036702","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21036702","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W71866488","https://openalex.org/W1509901905","https://openalex.org/W1538419182","https://openalex.org/W1577285130","https://openalex.org/W1678689855","https://openalex.org/W1970924670","https://openalex.org/W1973792489","https://openalex.org/W1986536800","https://openalex.org/W1991324349","https://openalex.org/W2004284414","https://openalex.org/W2007444742","https://openalex.org/W2010359358","https://openalex.org/W2018305254","https://openalex.org/W2022811243","https://openalex.org/W2041855451","https://openalex.org/W2044807782","https://openalex.org/W2050540135","https://openalex.org/W2061497413","https://openalex.org/W2078751203","https://openalex.org/W2080125477","https://openalex.org/W2081184407","https://openalex.org/W2088231104","https://openalex.org/W2102273204","https://openalex.org/W2102752109","https://openalex.org/W2120729899","https://openalex.org/W2128252882","https://openalex.org/W2133958296","https://openalex.org/W2137248525","https://openalex.org/W2142314780","https://openalex.org/W2145668050","https://openalex.org/W2146274229","https://openalex.org/W2151334179","https://openalex.org/W2156257249","https://openalex.org/W2156685281","https://openalex.org/W2157935840","https://openalex.org/W2161090683","https://openalex.org/W2165351839"],"related_works":["https://openalex.org/W2013951984","https://openalex.org/W1984844124","https://openalex.org/W2246611504","https://openalex.org/W1864471800","https://openalex.org/W2011554745","https://openalex.org/W2037689935","https://openalex.org/W2047504567","https://openalex.org/W2020302757","https://openalex.org/W2162472950","https://openalex.org/W2032590302"],"abstract_inverted_index":{"Inhibitors":[0],"of":[1,17,32,75,92,103,111,118,126,132],"topoisomerase":[2],"I,":[3],"such":[4],"as":[5],"camptothecin,":[6],"have":[7],"proven":[8],"to":[9,42,53],"be":[10,135],"among":[11],"the":[12,22,33,44,97],"most":[13,34],"promising":[14],"new":[15,137],"classes":[16],"anti-neoplastic":[18],"agents":[19],"introduced":[20],"into":[21],"clinical":[23],"setting":[24],"in":[25,63,83,140],"recent":[26],"years.":[27],"Irinotecan":[28],"(CPT-11)":[29],"is":[30,40],"one":[31],"widely":[35],"used":[36],"camptothecin":[37],"analogs":[38],"and":[39,59,66,77,94,105,120],"converted":[41],"form":[43],"active":[45],"metabolite":[46],"SN-38.":[47],"The":[48,70],"present":[49],"study":[50],"was":[51],"designed":[52],"explore":[54],"apoptosis":[55,82,123],"induced":[56],"by":[57],"SN38":[58,76,93,119],"anti-Fas":[60],"antibody":[61],"(CH11)":[62],"WR/Fas-SMS1":[64,84],"cells":[65],"its":[67],"possible":[68],"mechanisms.":[69],"results":[71],"demonstrate":[72],"that":[73,90,116],"combination":[74,91,117],"CH11":[78,95,121],"synergistically":[79],"enhanced":[80,122],"cell":[81],"cells.":[85],"Western":[86],"blotting":[87],"analysis":[88],"showed":[89],"activated":[96],"ATM-Chk1-p53":[98],"pathway,":[99],"increased":[100],"protein":[101],"expression":[102,110],"phospho-p53":[104],"cleavaged":[106],"caspase-3,":[107],"but":[108],"down-regulated":[109],"phospho-p21.":[112],"Our":[113],"data":[114],"suggest":[115],"through":[124],"down-regulation":[125],"p21":[127,133],"phosphorylation.":[128],"In":[129],"conclusion,":[130],"inhibition":[131],"could":[134],"a":[136],"adjuvant":[138],"approach":[139],"cancer":[141],"therapy.":[142]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}